PINS - Why Is Biophytis (BPTS) Stock Up 69% Today?
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Biophytis (NASDAQ:BPTS) stock is taking off on Thursday after the company released results from a Phase 2/3 clinical trial.
That clinical trial covers the use of Sarconeos as a treatment for patients suffering from COVID-19-related respiratory failure. The positive news is the clinical trial meeting its primary endpoint with a 44% statistically significant reduction in the “risk of respiratory failure or early death in hospitalized patients with severe COVID-19.”
Biophytis notes that it’s already begun key regulatory activities needed to provide Sarconeos to Covid-19 patients. It’s working for Early Access Programs in both France and Brazil, as well as Marketing Authorisation in Europe, and Emergency Use Authorization in the U.S.
Stanislas Veillet, CEO of Biophytis, said the following in a news release.
‘While there is a resurgence of COVID-19 patients in China and still unacceptable levels of patients dying from COVID-19 in Europe, the USA and Brazil, Sarconeos (BIO101) may offer an effective therapeutic option to reduce further the threat of COVID-19 pandemic.”
BPTS Stock Movement
With today’s news of the clinical trial results comes heavy trading of BPTS stock. As of this writing, more than 23 million shares of the stock have been traded. That’s a massive surge in trading compared to the company’s daily average volume of about 128,000 shares.
BPTS stock is up 68.9% as of Thursday morning.
Investors looking for more of the latest stock market news will want to stick around!
InvestorPlace is ready to go Thursday with our deep dives into today’s biggest market stories. Among that is what has shares of Pinterest (NYSE:PINS), Okta (NASDAQ:OKTA), and Exact Sciences (NASDAQ:EXAS) stock in the news this morning. You can check out all of that at the following links!
More Thursday Stock Market News
- Pinterest Layoffs 2023: What to Know About the Latest PINS Job Cuts
- Okta Layoffs 2023: What to Know About the Latest OKTA Job Cuts
- Cathie Wood Is Doubling Down on This Hidden-Gem Artificial Intelligence Stock
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that? InvestorPlace.com’s writers disclose this fact and warn readers of the risks.
Read More:?Penny Stocks — How to Profit Without Getting Scammed
More From InvestorPlace
- Buy This $5 Stock BEFORE This Apple Project Goes Live
- The Best $1 Investment You Can Make Today
- It doesn’t matter if you have $500 or $5 million. Do this now.
- Massive Bear Market “Divergence Event” Ahead… And The #1 Way to Play It
The post Why Is Biophytis (BPTS) Stock Up 69% Today? appeared first on InvestorPlace.